Skip to content

Spot-Check Noninvasive Pulse CO-Oximeter Validation

Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02782806
Enrollment
368
Registered
2016-05-25
Start date
2016-04-11
Completion date
2016-05-19
Last updated
2019-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anemia

Keywords

Noninvasive, Pulse, CO-Oximeter, Validation

Brief summary

In this study, the accuracy of a noninvasive hemoglobin sensor(s) will be assessed by comparison to hemoglobin measurements from a laboratory analyzer.

Interventions

DEVICEMasimo Rad-67 Pulse Oximeter

Noninvasive pulse oximeter

Sponsors

Masimo Corporation
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
1 Months to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Male or female * Age: Greater than one month * Weight: Greater than or equal to 3kg * Any racial or ethnic group * The subject or the subject's legally authorized representative has given written informed consent/assent to participate in the study * If an ICU patient, total hemoglobin of \< 9 g/dL at time of screening.

Exclusion criteria

* Subjects with skin abnormalities at the planned application sites that may interfere with sensor application, per directions-for-use (DFU) or trans-illumination of the site, such as burns, scar tissue, nail polish, acrylic nails, infections, abnormalities, etc. * Subjects deemed not suitable for the study at the discretion of the investigator * Subjects unlikely to be able to refrain from excessive motion during data collection. Excessive motion includes postural changes, making hand gestures, involuntary muscular movements, etc.

Design outcomes

Primary

MeasureTime frameDescription
Accuracy of sensorUp to 1 hr per subjectAccuracy willl be determined by comparing the noninvasive hemoglobin measurement of the pulse oximeter to the hemoglobin value obtained from a blood sample and calculating the arithmetic root mean square(Arms) error value.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026